A global movement is underway to rename Polycystic Ovary Syndrome (PCOS), and it’s being driven not just by researchers, but by the people living with the condition every day.
A major international study led by Monash University reveals a clear consensus: the current name is outdated, misleading, and no longer reflects the true nature of the condition. Across surveys conducted in 2015 and 2023, involving 7,708 patients and healthcare professionals from six continents, the majority agreed that a name change is necessary to improve understanding, diagnosis, and care.
The Core Problem: Researchers Say PCOS Has a Misleading Name
PCOS affects one in eight women, but despite being the most common endocrine disorder in reproductive-aged women, PCOS is still widely misunderstood. The term itself places emphasis on “ovaries” and “cysts”, yet many individuals with PCOS do not have ovarian cysts, and the condition extends far beyond reproductive health.
Experts argue that this narrow framing has real consequences:
- Delayed or missed diagnoses
- Fragmented care across specialties
- Limited patient understanding
- Underinvestment in research
As Professor Helena Teede, lead author of the study, explains, the current name “does not reflect the broad range of health impacts” and contributes to confusion in both clinical and patient settings.
Strong Global Support for Change
A 2023 global survey published by researchers at Monash University, involving more than 7,700 health professionals and patients, found that 76% of clinicians and 86% of people with the condition supported renaming it. The main reason? The name "polycystic ovary syndrome" implies it is only a condition of the ovaries, when in reality, it's much broader.
“One in eight women are affected by this, and quite profoundly, and to have this then sidetracked, that there may be a metabolic subtype in males …” said Teede, “that’s not going to change the very significant impact and neglect that this condition has had in women’s health for a long time.” Prof. Helena Teede, Monash University
The data is unequivocal:
- 76% of healthcare professionals and 86% of patients support renaming PCOS
- Up to 90% identified clear advantages to a new name
- Fewer than 27% noted potential downsides
Rather than being a controversial shift, the renaming effort is widely seen as overdue.
What Would a New Name Look Like for PCOS?
While no final name has been selected, the research shows a clear directional preference. Terms like “endocrine” and “metabolic” are among the most supported, reflecting the condition’s systemic nature rather than limiting it to reproductive anatomy.
Importantly, the process is not arbitrary. A structured, multi-step global consensus is already underway, involving:
- Medical experts
- Patient advocacy groups
- Cultural and regional stakeholders
The goal is to ensure the new name is medically accurate, globally relevant, and sensitive to diverse populations.
Why This Matters Beyond Semantics
This isn’t just a branding exercise as some people are saying, it’s a clinical and societal shift.
A more accurate name has the potential to:
- Improve early diagnosis and intervention
- Align care across endocrinology, dermatology, cardiometabolic, and mental health disciplines
- Increase funding and research attention
- Reduce stigma and patient frustration
Dr. Mahnaz Bahri Khomami, co-lead of the initiative, emphasizes that the aim is to “more accurately frame PCOS beyond a reproductive disorder” and ultimately improve outcomes without disrupting diagnostic consistency.
Why Is This Relevant Now If the PCOS Name Change Conversation Started in 2023?
While the global survey that accelerated the push to rename PCOS was conducted in 2023, this is not a “past” conversation, it’s an active, evolving process that is gaining renewed momentum in 2025 and 2026.
First, the renaming initiative itself is still underway. The multi-step global consensus process, led by major research institutions and patient advocacy groups, is ongoing, with a final name expected as early as 2026 following continued data collection, review, and implementation planning.In other words, we are not looking at a completed decision, we are in the critical phase where awareness, participation, and public conversation can still influence the outcome.
At the same time, media coverage has picked back up. Major health and news outlets have revisited the topic throughout 2025 and into 2026, emphasizing that the current name is misleading, outdated, and a barrier to proper diagnosis, funding, and care. Even recent 2026 coverage highlights ongoing calls from researchers and patients to rethink the name, reinforcing that this is still a live issue in the medical and public discourse, not a closed chapter.
But what’s equally important, and often overlooked, is what’s happening outside of academic and clinical spaces.
The Cultural Layer: Community Conversations Are Driving Visibility
Beyond journals and institutions, the conversation has gained traction across digital communities, particularly:
@karina.pcos a big announcement for pcos that experts have been campaigning for over a decade 📣 this is led by monash university in australia in collaboration with uk pcos charity verity and androgen excess and pcos society! what do you think of the pcos name change? what do you think the name will be? #pcos #pcoslife #pcosresearch #pcosproblems #pcossupport ♬ original sound - karina.pcos
- Reddit (e.g., r/PCOS): where users actively discuss the confusion caused by the name, share diagnostic journeys, and debate what a better name should reflect
- TikTok: where creators with PCOS are breaking down why the term is inaccurate, often highlighting that “you don’t need cysts to have PCOS” and calling for a reframe. But also, saying that the doctors are more focused on the name than to do the research to provide better guidance to a condition that affects their daily routine.
- Online patient communities and forums: where misinformation, frustration with delayed diagnoses, and lack of clarity are recurring themes.
This aligns with what research and clinicians are already acknowledging: misinformation and confusion, often amplified online, are directly tied to the limitations of the current name.
In fact, mainstream media has also pointed out how people with PCOS often feel they have to “fight” for diagnosis and navigate a flood of inconsistent information, much of it circulating on social platforms.
Why This Moment Matters for the PCOS Community
What makes this moment different is the convergence of three forces:
- Scientific consensus (strong global support for renaming)
- Institutional action (formal renaming process actively in progress)
- Cultural amplification (patients driving awareness on social platforms)
That combination is what turns a research finding into a real shift in how a condition is understood, diagnosed, and treated.
So while the groundwork may have started years ago, this is the moment where the conversation is becoming mainstream, and where it can actually lead to change.
The Patient Perspective: Long Overdue
For many living with PCOS, the change is deeply personal.
Lorna Berry, who is part of the international renaming effort, describes the current term as “misleading, medically outdated, and emotionally invalidating.” She highlights a reality many patients share: years of պայք to get diagnosed, followed by ongoing misinformation even after.
The renaming effort represents something bigger: validation, clarity, and meaningful progress. While some people on the PCOS community online argue that changing the name distracts from more urgent gaps in care, many cysters see it differently, they view it as long overdue and as a necessary step toward holding women’s healthcare to a higher standard.
What Happens Next?
The process is actively moving forward. A new global survey is open to both patients and healthcare professionals, forming part of the structured pathway toward finalizing a new name.
Organizations including:
- The NHMRC Centre for Research Excellence in Women’s Health in Reproductive Life (CRE-WHiRL)
- The Androgen Excess and PCOS Society (AE-PCOS)
- Verity (UK-based PCOS advocacy group)
are leading this effort, alongside international collaborators.
Bottom Line
The push to rename PCOS reflects a broader evolution in how the condition is understood. As awareness grows, so does the need for language that accurately represents its complexity.
Because when the name is wrong, everything that follows, diagnosis, treatment, perception, can be too.
What You Can Do Right Now as a PCOS Girly
Whether you've been diagnosed with PCOS, suspect you may have it, or simply want to understand your hormonal health better, here are some grounded steps:
-
Ask about metabolic screening. If you have PCOS, ask your doctor about blood sugar, insulin, lipid levels, and cardiovascular markers, not just reproductive health.
-
Know your family history. Research suggests metabolic patterns run in families. Sharing information about relatives' health with your provider can be valuable.
-
Focus on lifestyle consistency. Sustainable nutrition, regular movement, and stress management are among the most well-researched supportive strategies.
-
Ask about supplement research. If you're curious about nutritional support, ask your healthcare provider about the evidence behind specific nutrients studied in hormonal health contexts.
-
Stay informed. A new name for this condition is expected to be officially announced soon. Follow credible sources and ask your doctor how it might affect your care.
A note on supplement quality: If you choose to explore nutritional supplements as part of a broader wellness routine, look for products manufactured in NSF- and GMP-certified facilities. These certifications reflect rigorous quality standards for ingredient purity and manufacturing processes. Always discuss any supplement use with your healthcare provider before starting.
References
1. Teede HJ, et al. "Polycystic ovary syndrome." Nature Reviews Disease Primers, 2024. doi:10.1038/s41572-024-00540-y
2. Balen AH, et al. "'Tis but thy name that is my enemy." Fertility and Sterility, 2023. doi:10.1016/j.fertnstert.2023.07.016
3. Teede HJ, et al. "Global survey on PCOS name change." Monash University Centre for Research Excellence in Women's Health, 2023.
4. Zhu J, et al. "Genetic risk scores for PCOS and metabolic phenotypes in males." Research from Boston Children's Hospital, published 2023–2024.
5. Sam S. "Metabolic abnormalities in polycystic ovary syndrome: Clinical and hormonal outcomes." Diabetes Spectrum, 2007.
6. World Health Organization. "Polycystic ovary syndrome." WHO Fact Sheet, 2023. Available at: who.int
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. "Revised 2003 consensus on diagnostic criteria and long-term health risks." Human Reproduction, 2004.
8. Azziz R, et al. "The prevalence and features of the polycystic ovary syndrome in an unselected population." Journal of Clinical Endocrinology & Metabolism, 2004.
